The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in Southeast Asia: A cluster randomised trial
ConclusionsAdded to community-based basic malaria control measures, 3 monthly rounds of DP MDA reduced the incidence and prevalence of falciparum malaria over a 1-year period in areas affected by artemisinin resistance.P.falciparum infections returned during the follow-up period as the remaining infections spread and malaria was reintroduced from surrounding areas. Limitations of this study include a relatively small sample of villages, heterogeneity between villages, and mobility of villagers that may have limited the impact of the intervention. These results suggest that, if used as part of a comprehensive, well-organised, and well-resourced elimination programme, DP MDA can be a useful additional tool to accelerate malaria elimination. Trial registrationClinicalTrials.gov NCT01872702
Source: PLoS Medicine - Category: Internal Medicine Authors: Lorenz von Seidlein Source Type: research
More News: Cambodia Health | Internal Medicine | Malaria | Multidrug Resistance | Myanmar Health | Parasitic Diseases | Parasitology | Study | Vietnam Health